Clinical Trial Update: Phase I/II Study of KP-100IT in Acute Spinal Cord Injury [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II clinical trial update for KP-100IT in acute spinal cord injury has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• KP-100IT

Snippet

Sponsor: Kringle Pharma, Inc. | Conditions: Spinal Cord Injuries | Phase 1, Phase 2 | Status: COMPLETED